Chuandong Geng

Peer-Reviewed Articles

1. Geng, C, Zhang, MC, Manyam, GC, Vykoukal, JV, Fahrmann, JF, Peng, S, Wu, C, Park, SH, Kondraganti, S, Wang, D, Robinson, B, Loda, M, Barbieri, CE, Yap, TA, Corn, P, Hanash, S, Broom, BM, Pilie, PG, Thompson, T. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression. Clinical Cancer Research 29(21):4464-4478, 2023. PMID: 37581614.

Letters to the Editor

1. Geng, C, Thompson, T. DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer. Engineering 12: 12-15, 2022.